Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Free Cash Flow (2022 - 2025)

CervoMed (CRVO) has disclosed Free Cash Flow for 9 consecutive years, with -$6.6 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 18.32% to -$6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$23.4 million through Dec 2025, down 41.86% year-over-year, with the annual reading at -$23.4 million for FY2025, 41.86% down from the prior year.
  • Free Cash Flow hit -$6.6 million in Q4 2025 for CervoMed, down from -$6.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $6.9 million in Q3 2022 to a low of -$8.1 million in Q4 2024.
  • Historically, Free Cash Flow has averaged -$3.1 million across 4 years, with a median of -$3.2 million in 2023.
  • Biggest YoY gain for Free Cash Flow was 68.67% in 2023; the steepest drop was 266.55% in 2023.
  • Year by year, Free Cash Flow stood at -$692530.0 in 2022, then crashed by 266.55% to -$2.5 million in 2023, then crashed by 217.16% to -$8.1 million in 2024, then grew by 18.32% to -$6.6 million in 2025.
  • Business Quant data shows Free Cash Flow for CRVO at -$6.6 million in Q4 2025, -$6.5 million in Q3 2025, and -$6.5 million in Q2 2025.